Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Combination Gefitinib and Methotrexate to treat Ectopic Pregnancies: Phase 1 GEM
Horne, Andrew
(Principal Investigator)
Deanery of Clinical Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/02/11
→
31/12/14
Funding
Non-EU other:
£60,591.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Cohort Study
Pharmacology, Toxicology and Pharmaceutical Science
100%
Methotrexate
Pharmacology, Toxicology and Pharmaceutical Science
100%
Ectopic Pregnancy
Pharmacology, Toxicology and Pharmaceutical Science
100%
Single Drug Dose
Biochemistry, Genetics and Molecular Biology
100%
Combination Therapy
Pharmacology, Toxicology and Pharmaceutical Science
75%
Retrospective Study
Pharmacology, Toxicology and Pharmaceutical Science
25%
Research output
Research output per year
2013
2013
2013
1
Article
Research output per year
Research output per year
Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study
Skubisz, M., Dutton, P.,
Duncan, W. C.
,
Horne, A. W.
& Tong, S.,
1 Feb 2013
,
In:
BMC pregnancy and childbirth.
13
,
5 p.
, 30.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Cohort Study
100%
Ectopic Pregnancy
100%
Methotrexate
100%
Single Drug Dose
100%
Combination Therapy
75%